NCT05400148View on ClinicalTrials.gov

Dose and Concentration Relationship for PENG Block in Hip Surgery

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

May 5, 2023

Conditions
Hip FracturesPost Operative Pain
Interventions
DRUG

Bupivacaine Hydrochloride

Patients who were administered an analgesic PENG block with a dose of 2.5mg/kg with either lov (\<20ml) or high volume (\>20ml)

Trial Locations (1)

34384

Prof. Dr. Cemil Tascioglu City Hospital, Istanbul

All Listed Sponsors
lead

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

OTHER